{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:04:59Z","timestamp":1787238299940,"version":"build-2736575974"},"reference-count":147,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006345","name":"Uniwersytet Mikolaja Kopernika w Toruniu","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006345","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.mehy.2020.109791","type":"journal-article","created":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T10:50:21Z","timestamp":1588330221000},"page":"109791","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["The differential role of uric acid \u2013 The purpose or cause of cardiovascular diseases?"],"prefix":"10.1016","volume":"142","author":[{"given":"Emilia","family":"Siemi\u0144ska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemys\u0142aw","family":"Sobczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Skibi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Sikora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2020.109791_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2008.02.024","article-title":"The paradoxical relationship between serum uric acid and cardiovascular disease","volume":"392","author":"Lippi","year":"2008","journal-title":"Clin Chim Acta"},{"issue":"2","key":"10.1016\/j.mehy.2020.109791_b0010","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s12291-009-0038-6","article-title":"Uric acid a better scavenger of free radicals than vitamin C in rheumatoid arthritis","volume":"24","author":"Mahajan","year":"2009","journal-title":"Indian J Clin Biochem"},{"key":"10.1016\/j.mehy.2020.109791_b0015","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0092-8674(81)90232-4","article-title":"Localization of xanthine oxidase in mammary-gland endothelium and capillary endothelium","volume":"25","author":"Jarasch","year":"1981","journal-title":"Cell"},{"issue":"18","key":"10.1016\/j.mehy.2020.109791_b0020","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1001\/jama.283.18.2404","article-title":"Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971\u20131992","volume":"283","author":"Fang","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.mehy.2020.109791_b0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.atherosclerosis.2008.05.022","article-title":"Uric acid: a marker of increased cardiovascular risk","volume":"202","author":"Gagliardi","year":"2009","journal-title":"Atherosclerosis"},{"issue":"17","key":"10.1016\/j.mehy.2020.109791_b0030","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","article-title":"Uric acid and cardiovascular risk","volume":"359","author":"Feig","year":"2008","journal-title":"N J Med"},{"issue":"409","key":"10.1016\/j.mehy.2020.109791_b0035","first-page":"414","article-title":"Uric acid and oxidative stress: relative impact on cardiovascular risk","volume":"17","author":"Strazzullo","year":"2007","journal-title":"Nutrit, Metab Cardiov Dis"},{"issue":"7","key":"10.1016\/j.mehy.2020.109791_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLOS Med"},{"key":"10.1016\/j.mehy.2020.109791_b0045","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/2046-4053-3-54","article-title":"Study flow diagrams in Cochrane systematic review updates: an adapted PRISMA flow diagram","volume":"3","author":"Stovold","year":"2014","journal-title":"System Rev"},{"issue":"2","key":"10.1016\/j.mehy.2020.109791_b0050","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.trsl.2013.02.006","article-title":"Effects of acute exercise and xanthine oxidase inhibition on novel cardiovascular biomarkers","volume":"162","author":"Sanchis-Gomar","year":"2013","journal-title":"Transl Res"},{"key":"10.1016\/j.mehy.2020.109791_b0055","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1253\/circj.70.1006","article-title":"Serum level of uric acid, partly secreted from the failing heart, is a prognostic marker in patients with congestive heart failure","volume":"70","author":"Sakai","year":"2006","journal-title":"Circ J"},{"key":"10.1016\/j.mehy.2020.109791_b0060","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijcard.2015.08.088","article-title":"Uric acid-lowering therapy in cardiovascular diseases","volume":"213","author":"Volterrani","year":"2016","journal-title":"Int J of Cardiol"},{"key":"10.1016\/j.mehy.2020.109791_b0065","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/01.HYP.0000069700.62727.C5","article-title":"Kivlighn et al.: is there a pathogenic role for uric acid in hypertension and cardiovascular and renal disease","volume":"41","author":"Johnson","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.mehy.2020.109791_b0070","first-page":"162","article-title":"On-admission serum uric acid predicts outcomes after acute myocardial infarction: systematic review and meta-analysis of prognostic studies","volume":"53","author":"Trkulja","year":"2012","journal-title":"Clin Sci"},{"issue":"4","key":"10.1016\/j.mehy.2020.109791_b0075","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/archinte.1975.00330040021002","article-title":"Corneal arcus and cardiovascular disease in evans county","volume":"135","author":"Kelin","year":"1975","journal-title":"Georgia Arch Intern Med"},{"key":"10.1016\/j.mehy.2020.109791_b0080","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/01.CIR.59.5.969","article-title":"Uric acid: a risk factor for coronary heart disease?","volume":"59","author":"Persky","year":"1979","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2020.109791_b0085","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.0954-6820.1982.tb08521.x","article-title":"Hyperuricemia as a risk factor for cardiovascular mortality","volume":"668","author":"Reunanen","year":"1982","journal-title":"Acta Med Scand Suppl"},{"issue":"5","key":"10.1016\/j.mehy.2020.109791_b0090","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/oxfordjournals.aje.a113787","article-title":"Ten-year incidence of coronary heart disease in the Honolulu Heart Program. Relationship to biologic and lifestyle characteristics","volume":"119","author":"Yano","year":"1984","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.mehy.2020.109791_b0095","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/oxfordjournals.aje.a113972","article-title":"Hyperuricemia as a risk factor of coronary heart disease: the Framingham Study","volume":"121","author":"Brand","year":"1985","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1016\/j.mehy.2020.109791_b0100","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.0954-6820.1988.tb19625.x","article-title":"Hyperuricaemia and risk of cardiovascular disease and overall death. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden","volume":"224","author":"Bengtsson","year":"1988","journal-title":"Acta Med Scand."},{"issue":"3","key":"10.1016\/j.mehy.2020.109791_b0105","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0895-4356(89)90061-9","article-title":"Serum uric acid and 11.5-year mortality of middle-aged women: findings of the Chicago Heart Association Detection Project in Industry","volume":"42","author":"Levine","year":"1989","journal-title":"J Clin Epidemiol"},{"issue":"3A","key":"10.1016\/j.mehy.2020.109791_b0110","first-page":"50S","article-title":"The determinants and prognostic significance of serum uric acid in elderly patients of the European Working Party on High Blood Pressure in the Elderly trial","volume":"90","author":"Staessen","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.mehy.2020.109791_b0115","first-page":"637","article-title":"Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study","author":"Freedman","year":"199511417","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1016\/j.mehy.2020.109791_b0120","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0895-4356(96)00034-0","article-title":"High uric acid: a metabolic marker of coronary heart disease among alcohol abstainers","volume":"49","author":"Iribarren","year":"1996","journal-title":"J Clin Epidemiol"},{"issue":"10","key":"10.1016\/j.mehy.2020.109791_b0125","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1161\/01.CIR.94.10.2381","article-title":"Serum lipids and incidence of coronary heart disease: findings from the systolic hypertension in the elderly program (SHEP)","volume":"94","author":"Frost","year":"1996","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.mehy.2020.109791_b0130","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/hrt.78.2.147","article-title":"Serum urate and the risk of major coronary heart disease events","volume":"78","author":"Wannamethee","year":"1997","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.mehy.2020.109791_b0135","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1047-2797(97)00204-4","article-title":"Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: the CARDIA study. Coronary Artery Risk Development in Young Adults","volume":"8","author":"Rathmann","year":"1998","journal-title":"Ann Epidemiol"},{"issue":"4","key":"10.1016\/j.mehy.2020.109791_b0140","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00001648-199907000-00009","article-title":"Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort. World Health Organization Monitoring Trends and Determinants in Cardiovascular Diseases","volume":"10","author":"Liese","year":"1999","journal-title":"Epidemiology"},{"key":"10.1016\/j.mehy.2020.109791_b0145","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7326\/0003-4819-131-1-199907060-00003","article-title":"Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study","volume":"131","author":"Culleton","year":"1999","journal-title":"Ann Internal Med"},{"key":"10.1016\/j.mehy.2020.109791_b0150","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1161\/01.HYP.34.1.144","article-title":"Serum uric acid and cardiovascular events in successfully treated hypertensive patients","volume":"34","author":"Alderman","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.mehy.2020.109791_b0155","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1047-2797(99)00037-X","article-title":"Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study","volume":"10","author":"Moriarity","year":"2000","journal-title":"Ann Epidemiol"},{"issue":"6","key":"10.1016\/j.mehy.2020.109791_b0160","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/01.HYP.36.6.1072","article-title":"Relation between serum uric acid and risk of cardiovascular disease in essential","volume":"36","author":"Verdecchia","year":"2000","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/j.mehy.2020.109791_b0165","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/00004872-200018080-00021","article-title":"Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP)","volume":"18","author":"Franse","year":"2000","journal-title":"J Hypertens"},{"issue":"12","key":"10.1016\/j.mehy.2020.109791_b0170","first-page":"1679","article-title":"Is serum uric acid level associated with all-cause mortality in high-functioning older persons: MacArthur studies of successful aging?","volume":"49","author":"Hu","year":"2001","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"10.1016\/j.mehy.2020.109791_b0175","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1023\/A:1021216713504","article-title":"Predictors of stroke mortality in elderly people from the general population. The CArdiovascular STudy in the ELderly","volume":"17","author":"Mazza","year":"2001","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"10.1016\/j.mehy.2020.109791_b0180","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2143\/AC.56.4.2005651","article-title":"Serum uric acid for short-term prediction of cardiovascular disease incidence in the Gubbio population Study","volume":"56","author":"Puddu","year":"2001","journal-title":"Acta Cardiol"},{"issue":"4","key":"10.1016\/j.mehy.2020.109791_b0185","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/01.HYP.37.4.1069","article-title":"Prognostic significance of serum creatinine and uric acid in older chinese patients with isolated systolic hypertension","volume":"37","author":"Wang","year":"2001","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.mehy.2020.109791_b0190","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1053\/euhj.2001.2970","article-title":"Urate predicts subsequent cardiac death in stroke survivors","volume":"23","author":"Wong","year":"2002","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.mehy.2020.109791_b0195","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1097\/01.ASN.0000027871.86296.92","article-title":"Prognostic significance of renal function in elderly patients with isolated systolic hypertension: results from the Syst-Eur trial","volume":"13","author":"De Leeuw","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.mehy.2020.109791_b0200","first-page":"12","article-title":"Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease","author":"Bickel","year":"20021891","journal-title":"Am J Cardiol"},{"issue":"8","key":"10.1016\/j.mehy.2020.109791_b0205","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1161\/01.STR.0000081983.34771.D2","article-title":"Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke","volume":"34","author":"Weir","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.mehy.2020.109791_b0210","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1161\/01.CIR.0000065637.10517.A0","article-title":"Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging","volume":"22;107;15","author":"Anker","year":"2003","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.mehy.2020.109791_b0215","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/01.hjr.0000130222.50258.22","article-title":"Serum uric acid and risk of death from cancer, cardiovascular disease or all causes in men","volume":"11","author":"Jee","year":"2004","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.mehy.2020.109791_b0220","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/archinte.164.14.1546","article-title":"Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study","volume":"26","author":"Niskanen","year":"2004","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.mehy.2020.109791_b0225","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1523-1755.2004.00484.x","article-title":"The impact of serum uric acid on cardiovascular outcomes in the LIFE study","volume":"65","author":"H\u00f8ieggen","year":"2004","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.mehy.2020.109791_b0230","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1185\/030079904125004484","article-title":"Relationship between LDL-C and non-HDL-C levels and clinical outcome in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study","volume":"20","author":"Athyros","year":"2004","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"10.1016\/j.mehy.2020.109791_b0235","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.atherosclerosis.2005.09.020","article-title":"Serum uric acid and risk of ischemic stroke: the ARIC Study","volume":"187","author":"Hozawa","year":"2006","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.mehy.2020.109791_b0240","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.atherosclerosis.2005.01.018","article-title":"Hyperuricemia as a risk factor on cardiovascular events in Taiwan: the Chin-Shan Community Cardiovascular Cohort Study","volume":"183","author":"Chien","year":"2005","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.mehy.2020.109791_b0245","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/01.hjr.0000192745.26973.00","article-title":"Serum uric acid and long-term mortality from stroke, coronary heart disease and all causes","volume":"13","author":"Gerber","year":"2006","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"8","key":"10.1016\/j.mehy.2020.109791_b0250","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1002\/art.22014","article-title":"Gout and the risk of acute myocardial infarction","volume":"54","author":"Krishnan","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.mehy.2020.109791_b0255","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/art.23121","article-title":"Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study","volume":"58","author":"Ioachimescu","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.mehy.2020.109791_b0260","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1373\/clinchem.2007.094425","article-title":"Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83,683 Austrian men","volume":"54","author":"Strasak","year":"2008","journal-title":"Clin Chem"},{"key":"10.1016\/j.mehy.2020.109791_b0265","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ijcard.2007.11.094","article-title":"Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: a prospective 21-year follow-up study","volume":"10","author":"Strasak","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.mehy.2020.109791_b0270","first-page":"225","article-title":"Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study","author":"Chen","year":"200915612","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.mehy.2020.109791_b0275","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3899\/jrheum.080646","article-title":"Serum uric acid is associated with carotid plaques: the National Heart, Lung, and Blood Institute Family Heart Study","volume":"36","author":"Neogi","year":"2009","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.mehy.2020.109791_b0280","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/art.24612","article-title":"Hyperuricemia and risk of stroke: a systematic review and meta-analysis","volume":"61","author":"Kim","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.mehy.2020.109791_b0285","first-page":"1387","article-title":"Predictive value of serum uric acid on cardiovascular disease and all-cause mortality in urban Chinese patients","volume":"123","author":"Wu","year":"2010","journal-title":"Chin Med J (Eng)"},{"issue":"2","key":"10.1016\/j.mehy.2020.109791_b0290","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1053\/j.ajkd.2010.01.024","article-title":"Is high serum uric acid a risk marker or a target for treatment? examination of its independent effect in a large cohort with low cardiovascular risk","volume":"56","author":"Wen","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.mehy.2020.109791_b0295","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/acr.20344","article-title":"Hyperuricemia and incident hypertension: a systematic review and meta-analysis","volume":"63","author":"Grayson","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"10.1016\/j.mehy.2020.109791_b0300","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1177\/0003319711421341","article-title":"Long-term impact of multifactorial treatment on new-onset diabetes and related cardiovascular events in metabolic syndrome: a post hoc ATTEMPT analysis","volume":"63","author":"Athyros","year":"2012","journal-title":"Angiology"},{"issue":"8","key":"10.1016\/j.mehy.2020.109791_b0305","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1185\/03007995.2011.595782","article-title":"Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT study","volume":"27","author":"Athyros","year":"2011","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"10.1016\/j.mehy.2020.109791_b0310","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1053\/j.ajkd.2011.04.025","article-title":"Joint association of hyperuricemia and reduced GFR on cardiovascular morbidity: a historical cohort study based on laboratory and claims data from a national insurance provider","volume":"58","author":"Neri","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1016\/j.mehy.2020.109791_b0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045907","article-title":"Relationship between inflammatory cytokines and uric acid levels with adverse cardiovascular outcomes in patients with stable coronary heart disease","volume":"7","author":"Rothenbacher","year":"2012","journal-title":"PLoS ONE"},{"issue":"154","key":"10.1016\/j.mehy.2020.109791_b0320","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ijcard.2011.06.055","article-title":"Hyperuricemia and increased risk of ischemic heart disease in a large Chinese cohort","volume":"9","author":"Chuang","year":"2012","journal-title":"Int J Cardiol"},{"issue":"167","key":"10.1016\/j.mehy.2020.109791_b0325","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ijcard.2011.12.110","article-title":"Uric acid: a cardiovascular risk factor in patients with recent myocardial infarction","volume":"15","author":"Levantesi","year":"2013","journal-title":"Int J Cardiol"},{"issue":"111","key":"10.1016\/j.mehy.2020.109791_b0330","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.amjcard.2012.12.034","article-title":"Association of serum uric acid and cardiovascular disease in healthy adults","volume":"15","author":"Kivity","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.mehy.2020.109791_b0335","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.numecd.2011.02.008","article-title":"Uric acid is predictive of cardiovascular mortality and sudden cardiac death in subjects referred for coronary angiography","volume":"1","author":"Silbernagel","year":"2013","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"7","key":"10.1016\/j.mehy.2020.109791_b0340","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.hrthm.2014.04.003","article-title":"Association between serum uric acid and atrial fibrillation: a systematic review and meta-analysis","volume":"1","author":"Tamariz","year":"2014","journal-title":"Heart Rhythm"},{"issue":"9","key":"10.1016\/j.mehy.2020.109791_b0345","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1177\/0003319713507628","article-title":"Serum concentration of uric acid associated with prehypertension among Chinese population","volume":"65","author":"Bao","year":"2014","journal-title":"Angiology"},{"issue":"12","key":"10.1016\/j.mehy.2020.109791_b0350","article-title":"Hyperuricemia and risk of incident hypertension: a systematic review and meta-analysis of observational studies","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS ONE"},{"issue":"11","key":"10.1016\/j.mehy.2020.109791_b0355","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/ejhf.419","article-title":"Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the High-Risk Myocardial Infarction Database Initiative","volume":"17","author":"von Lueder","year":"2015","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"10.1016\/j.mehy.2020.109791_b0360","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1681\/ASN.2014070660","article-title":"Uric acid and cardiovascular events: a Mendelian randomization study","volume":"26","author":"Kleber","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"197","key":"10.1016\/j.mehy.2020.109791_b0365","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ijcard.2015.06.069","article-title":"Uric acid is an independent predictor of cardiovascular events in post-menopausal women","volume":"15","author":"Sciacqua","year":"2015","journal-title":"Int J Cardiol"},{"issue":"15","key":"10.1016\/j.mehy.2020.109791_b0370","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12872-015-0059-4","article-title":"The association between serum uric acid levels, metabolic syndrome and cardiovascular disease in middle aged and elderly Chinese: results from the DYSlipidemia International Study","volume":"11","author":"Tian","year":"2015","journal-title":"BMC Cardiovascular Disord"},{"issue":"8","key":"10.1016\/j.mehy.2020.109791_b0375","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jash.2015.05.010","article-title":"Uric acid levels within the normal range predict increased risk of hypertension: a cohort study","volume":"9","author":"Leiba","year":"2015","journal-title":"J Am Soc Hypertens"},{"issue":"446","key":"10.1016\/j.mehy.2020.109791_b0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2015.03.040","article-title":"Joint effects of serum uric acid and body mass index on risk of prehypertension in Chinese population","volume":"15","author":"Jiang","year":"2015","journal-title":"Clin Chim Acta"},{"issue":"11","key":"10.1016\/j.mehy.2020.109791_b0385","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2459\/JCM.0000000000000238","article-title":"Long-term prognostic role of uric acid in patients with ST-elevation myocardial infarction and renal dysfunction","volume":"16","author":"Lazzeri","year":"2015","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"2","key":"10.1016\/j.mehy.2020.109791_b0390","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s40520-015-0395-3","article-title":"Elevated serum uric acid is associated with vascular inflammation but not coronary artery calcification in the healthy octogenarians: the Brazilian study on healthy aging","volume":"28","author":"Malik","year":"2016","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.mehy.2020.109791_b0395","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.atherosclerosis.2016.10.006","article-title":"Elevated serum uric acid and risk of cardiovascular or all-cause mortality in people with suspected or definite coronary artery disease: a meta-analysis","volume":"254","author":"Wang","year":"2016","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1016\/j.mehy.2020.109791_b0400","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.numecd.2016.03.001","article-title":"Serum uric acid levels during dual antiplatelet therapy with ticagrelor or clopidogrel: results from a single-center study","volume":"26","author":"Nardin","year":"2016","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"8","key":"10.1016\/j.mehy.2020.109791_b0405","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/jhh.2016.4","article-title":"Higher serum uric acid level increases risk of prehypertension in subjects with normal glucose tolerance, but not pre-diabetes and diabetes","volume":"30","author":"Wu","year":"2016","journal-title":"J Hum Hypertens"},{"issue":"1","key":"10.1016\/j.mehy.2020.109791_b0410","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/jch.12627","article-title":"Association between serum uric acid levels\/hyperuricemia and hypertension among 85,286 Japanese Workers","volume":"18","author":"Yokokawa","year":"2016","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"2","key":"10.1016\/j.mehy.2020.109791_b0415","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1177\/0003319715585037","article-title":"Serum uric acid and prehypertension among adults free of cardiovascular diseases and diabetes: baseline of the Brazilian","volume":"67","author":"Lotufo","year":"2016","journal-title":"Angiology"},{"issue":"55","key":"10.1016\/j.mehy.2020.109791_b0420","first-page":"314","article-title":"Serum uric acid levels and risk of prehypertension: a meta-analysis","volume":"1","author":"Jiang","year":"2017","journal-title":"Clin Chem Lab Med"},{"issue":"231","key":"10.1016\/j.mehy.2020.109791_b0425","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijcard.2016.11.268","article-title":"Hyperuricemia is an independent competing risk factor for atrial fibrillation","volume":"15","author":"Kuwabara","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.mehy.2020.109791_b0430","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.yjmcc.2015.04.004","article-title":"Genome-wide association studies of late-onset cardiovascular disease","volume":"83","author":"Smith","year":"2015","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.mehy.2020.109791_b0435","doi-asserted-by":"crossref","unstructured":"D\u00f6ring A., Gieger Ch., Mehta D et al.: SLC2A9 influences uric acid concentrations with pronounced sex-specific effects Nat Genetics 2008;40;4;430\u201336.","DOI":"10.1038\/ng.107"},{"key":"10.1016\/j.mehy.2020.109791_b0440","doi-asserted-by":"crossref","unstructured":"Han X, Gui L, Liu B. Associations of the uric acid related genetic variants in SLC2A9 and ABCG2 loci with coronary heart disease risk. BMC Genetics 2014;16;4 (http:\/\/bmcgenet.biomedcentral.com\/articles\/10.1186\/s12863-015-0162-7).","DOI":"10.1186\/s12863-015-0162-7"},{"key":"10.1016\/j.mehy.2020.109791_b0445","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.exger.2010.04.004","article-title":"Biomarkers of protein oxidation from chemical, biological and medical point of view","volume":"45","author":"Breusing","year":"2010","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.mehy.2020.109791_b0450","doi-asserted-by":"crossref","unstructured":"Bruce N Ames, Richard Cathcart, Elizabeth Schwiers, Paul Hochstein, Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: A hypothesis, Proceedings of the National Academy of Sciences of the United States of America Biochemistry 1981;78;11: 6858-6862.","DOI":"10.1073\/pnas.78.11.6858"},{"issue":"239","key":"10.1016\/j.mehy.2020.109791_b0455","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/abio.1996.0292","article-title":"The ferric reducing ability of plasma (FRAP) as a measure of \u201cantioxidant power\u201d: the FRAP assay","volume":"15","author":"Benzie","year":"1996","journal-title":"Anal Biochem"},{"key":"10.1016\/j.mehy.2020.109791_b0460","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1600-0773.2003.pto930606.x","article-title":"Inhibition by uric acid of free radicals that damage biological molecules","volume":"93","author":"Muraoka","year":"2003","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1016\/j.mehy.2020.109791_b0465","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1046\/j.1365-2362.1997.1390687.x","article-title":"Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus","volume":"27","author":"Maxwell","year":"1997","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.mehy.2020.109791_b0470","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.2174\/138161205774913255","article-title":"Uric acid and oxidative stress","volume":"11","author":"Glantzounits","year":"2005","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.mehy.2020.109791_b0475","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00005344-200109000-00005","article-title":"Maxwell SR Systemic uric acid administration increases serum antioxidant capacity in healthy volunteers","volume":"38","author":"Waring","year":"2001","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.mehy.2020.109791_b0480","doi-asserted-by":"crossref","first-page":"5778","DOI":"10.1021\/ja00197a042","article-title":"Antioxidation mechanisms of uric acid","volume":"111","author":"Simie","year":"1989","journal-title":"J Am Chem Soc"},{"issue":"12","key":"10.1016\/j.mehy.2020.109791_b0485","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1681\/ASN.2005050572","article-title":"Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells","volume":"6","author":"Kang","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.mehy.2020.109791_b0490","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1161\/01.CIR.103.13.1813","article-title":"High-sensitivity C-reactive protein potential adjunct for global risk assessment in the primary prevention of cardiovascular disease","volume":"103","author":"Ridker","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2020.109791_b0495","doi-asserted-by":"crossref","unstructured":"Ridker PM, Rifai N, Rose L, M.S, Buring JE, Cook NR, Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events, N Engl J Med 2002;347:1557\u201365.","DOI":"10.1056\/NEJMoa021993"},{"key":"10.1016\/j.mehy.2020.109791_b0500","doi-asserted-by":"crossref","unstructured":"Jialal I, Devaraj S, The value of the high-sensitivity C-reactive protein assay as a risk marker, Am J Clin Pathol 2001;116;(Suppl 1);S108:S115.","DOI":"10.1309\/J63V-5LTH-WYFC-VDR5"},{"issue":"73","key":"10.1016\/j.mehy.2020.109791_b0505","first-page":"79","article-title":"Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors","volume":"167","author":"Saito","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.mehy.2020.109791_b0510","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0891-5849(02)00956-5","article-title":"Structure and function of xanthine oxidoreductase: where are we now?","volume":"33","author":"Harrison","year":"2002","journal-title":"Free Radical Biol Med"},{"key":"10.1016\/j.mehy.2020.109791_b0515","first-page":"164","article-title":"Properties of xanthine oxidase from human liver","volume":"191","author":"Della Corte","year":"1969","journal-title":"BBA"},{"key":"10.1016\/j.mehy.2020.109791_b0520","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM198501173120305","article-title":"Oxygen-derived free radicals in postischemic tissue injury","volume":"312","author":"McCord","year":"1985","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.mehy.2020.109791_b0525","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1080\/15257770802138558","article-title":"Uric acid: the oxidant-antioxidant paradox","volume":"27","author":"Sautin","year":"2008","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.mehy.2020.109791_b0530","doi-asserted-by":"crossref","first-page":"9748","DOI":"10.1073\/pnas.85.24.9748","article-title":"Antioxidant defenses and lipid peroxidation in human blood plasma","volume":"85","author":"Frei","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.mehy.2020.109791_b0535","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.numecd.2015.12.015","article-title":"Uric acid and high-residual platelet reactivity in patients treated with clopidogrel or ticagrelor","volume":"26","author":"Bickel","year":"2016","journal-title":"Nutrition, Metab Cardiovasc Dis"},{"issue":"5","key":"10.1016\/j.mehy.2020.109791_b0540","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.metabol.2014.01.010","article-title":"Impact of diabetes on uric acid and its relationship with the extent of coronary artery disease and platelet aggregation: a single-centre cohort study","volume":"63","author":"Verdoiaa","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.mehy.2020.109791_b0545","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1046\/j.1365-2362.1997.1390687.x","article-title":"Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus","volume":"27","author":"Maxwell","year":"1997","journal-title":"Eur J Clin Invest"},{"issue":"6","key":"10.1016\/j.mehy.2020.109791_b0550","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1080\/15257770802138558","article-title":"Uric acid: the oxidant-antioxidant paradox","volume":"27","author":"Sautin","year":"2008","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.mehy.2020.109791_b0555","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1053\/j.ajkd.2010.06.004","article-title":"Uric acid, CKD, and cardiovascular disease: confounders, culprits, and circles","volume":"56","author":"Tangri","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.mehy.2020.109791_b0560","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1161\/hs0402.105927","article-title":"Prognostic significance of uric acid serum concentration in patients with acute ischemic stroke","volume":"33","author":"Chamorro","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.mehy.2020.109791_b0565","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.atherosclerosis.2014.09.001","article-title":"F\u00f6rstermann. Vascular oxidative stress, nitric oxide and atherosclerosis","volume":"237","author":"Li","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.mehy.2020.109791_b0570","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.freeradbiomed.2013.02.012","article-title":"Advanced oxidation protein products induce cardiomyocyte death via Nox2\/Rac1\/superoxide-dependent TRAF3IP2\/JNK signaling","volume":"60","author":"Valente","year":"2013","journal-title":"Free Radical Biol Med"},{"key":"10.1016\/j.mehy.2020.109791_b0575","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.biopha.2009.10.002","article-title":"Energetic myocardial metabolism and oxidative stress: let's make hem our friends in the fight against heart failure","volume":"64","author":"Scolletta","year":"2010","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.mehy.2020.109791_b0580","doi-asserted-by":"crossref","unstructured":"Tamariz L, Hare J, M. Xanthine oxidase inhibitors in heart failure. Where do we go from here. Circulation. 2015;131;1741\u20131744.","DOI":"10.1161\/CIRCULATIONAHA.115.016379"},{"key":"10.1016\/j.mehy.2020.109791_b0585","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1007\/s12013-014-0101-7","article-title":"Uric acid as a predictor of in-hospital mortality in acute myocardial infarction: a meta-analysis","volume":"70","author":"Yan","year":"2014","journal-title":"Cell Biochem Biophys"},{"issue":"10","key":"10.1016\/j.mehy.2020.109791_b0590","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1097\/00004872-200110000-00021","article-title":"Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout","volume":"19","author":"W\u00fcrzner","year":"2001","journal-title":"J Hypertens"},{"key":"10.1016\/j.mehy.2020.109791_b0595","doi-asserted-by":"crossref","unstructured":"Farquharson CA, Butler R, Hill A, Belch JJ, Struthers AD, Allopurinol improves endothelial dysfunction in chronic heart failure, Circulation. 2002;9;106;2:221\u20136.","DOI":"10.1161\/01.CIR.0000022140.61460.1D"},{"key":"10.1016\/j.mehy.2020.109791_b0600","doi-asserted-by":"crossref","unstructured":"Doehner W, Schoene N, Rauchhaus M, Leyva-Leon F, Pavitt DV, Reaveley DA, Schuler G, Coats AJ, Anker SD, Hambrecht R, Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies, Circulation. 2002;4;105;22:2619\u201324.","DOI":"10.1161\/01.CIR.0000017502.58595.ED"},{"key":"10.1016\/j.mehy.2020.109791_b0605","doi-asserted-by":"crossref","unstructured":"George J,Carr E,Davies J,Belch JJ,Struthers A, High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid, Circulation. 2006;5;114;23:2508\u201316.","DOI":"10.1161\/CIRCULATIONAHA.106.651117"},{"issue":"1","key":"10.1016\/j.mehy.2020.109791_b0610","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.jhh.1001941","article-title":"Effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia in Chinese population","volume":"20","author":"Dang","year":"2006","journal-title":"J Hum Hypertens"},{"issue":"2","key":"10.1016\/j.mehy.2020.109791_b0615","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.amjhyper.2005.08.005","article-title":"Effect of losartan versus candesartan on uric acid, renal function, and fibrinogen in patients with hypertension and hyperuricemia associated with diuretics","volume":"19","author":"Rayner","year":"2006","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.mehy.2020.109791_b0620","doi-asserted-by":"crossref","unstructured":"Feig DI, Soletsky B, Johnson RJ, Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial, 2008; 27;300;8:924\u201332.","DOI":"10.1001\/jama.300.8.924"},{"issue":"1","key":"10.1016\/j.mehy.2020.109791_b0625","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/CIRCHEARTFAILURE.109.868604","article-title":"Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study","volume":"3","author":"Ogino","year":"2010","journal-title":"Circ Heart Fail"},{"issue":"2","key":"10.1016\/j.mehy.2020.109791_b0630","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1186\/ar2978","article-title":"The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial","volume":"12","author":"Becker","year":"2010","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.mehy.2020.109791_b0635","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1365-2125.2010.03887.x","article-title":"Impact of allopurinol use on urate concentration and cardiovascular outcome","volume":"71","author":"Wei","year":"2011","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"10.1016\/j.mehy.2020.109791_b0640","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1080\/15257770.2011.628356","article-title":"Effects of losartan\/hydrochlorothiazide on serum uric acid levels and blood pressure in hypertensive patients","volume":"30","author":"Fujimori","year":"2011","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"2","key":"10.1016\/j.mehy.2020.109791_b0645","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/acr.20680","article-title":"Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol","volume":"64","author":"Chohan","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"10.1016\/j.mehy.2020.109791_b0650","doi-asserted-by":"crossref","first-page":"737.e11","DOI":"10.1016\/j.jcrc.2012.03.011","article-title":"Uric acid, allopurinol therapy, and mortality in patients with acute heart failure\u2014results of the Acute HEart FAilure Database registry","volume":"27","author":"M\u00e1lek","year":"2012","journal-title":"J Crit Care"},{"issue":"9","key":"10.1016\/j.mehy.2020.109791_b0655","first-page":"1048","article-title":"Prednisone in uric acid lowering in symptomatic heart failure patients with hyperuricemia (PUSH-PATH) study","volume":"29","author":"Liu","year":"2013","journal-title":"Can J Cardiol"},{"issue":"24","key":"10.1016\/j.mehy.2020.109791_b0660","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/j.jacc.2013.07.074","article-title":"Allopurinol reduces left ventricular mass in patients with type 2 diabetes and left ventricular hypertrophy","volume":"62","author":"Szwejkowski","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.mehy.2020.109791_b0665","article-title":"Allopurinol therapy in gout patients does not associate with beneficial cardiovascular outcomes: a population-based matched-cohort study","volume":"4","author":"Kok","year":"2014","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.mehy.2020.109791_b0670","doi-asserted-by":"crossref","first-page":"316","DOI":"10.4103\/1319-2442.128520","article-title":"Allopurinol reduces cardiovascular risks and improves renal function in pre-dialysis chronic kidney disease patients with hyperuricemia","volume":"25","author":"Sezer","year":"2014","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"12","key":"10.1016\/j.mehy.2020.109791_b0675","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145193","article-title":"Effect of urate-lowering therapy on all-cause and cardiovascular mortality in hyperuricemic patients without gout: a case-matched cohort study","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.mehy.2020.109791_b0680","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3899\/jrheum.141037","article-title":"Prednisone in uric acid lowering in symptomatic heart failure patients with hyperuricemia \u2013 the PUSH-PATH3 study","volume":"42","author":"Meng","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.mehy.2020.109791_b0685","doi-asserted-by":"crossref","unstructured":"Givertz MM, Anstrom KJ, Redfield MM et al: Effects of xantine oxidase inhibition in hyperuricemic heart failure patients. The xanthine oxidase inhibition for hyperuricemic heart failure patients (EXACT-HF) Study. Circulation 2015;131;1763\u20131771.","DOI":"10.1161\/CIRCULATIONAHA.114.014536"},{"issue":"3","key":"10.1016\/j.mehy.2020.109791_b0690","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3109\/10641963.2014.933968","article-title":"Effect of losartan on serum uric acid in hypertension treated with a diuretic: the COMFORT study","volume":"37","author":"Matsumura","year":"2015","journal-title":"Clin Exp Hypertens"},{"issue":"6","key":"10.1016\/j.mehy.2020.109791_b0695","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/1755-5922.12215","article-title":"Allopurinol therapy improves vascular endothelial function in subjects at risk for cardiovascular diseases: a meta-analysis of randomized controlled trials","volume":"34","author":"Xin","year":"2016","journal-title":"Cardiovasc Ther"},{"issue":"28","key":"10.1016\/j.mehy.2020.109791_b0700","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004177","article-title":"Hyperuricemia and uncontrolled hypertension in treated hypertensive patients: K-MetS Study","volume":"95","author":"Cho","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.mehy.2020.109791_b0705","doi-asserted-by":"crossref","unstructured":"Borgi L, McMullan C, Wohlhueter A, Curhan GC, Fisher ND, Forman JP, Effect of Uric Acid-Lowering Agents on Endothelial Function: A Randomized, D, Hypertension. 2017;69:00-00.","DOI":"10.1161\/HYPERTENSIONAHA.116.08488"},{"issue":"5","key":"10.1016\/j.mehy.2020.109791_b0710","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1136\/annrheumdis-2016-209213","article-title":"Lesinurad in combination with allopurinol: a randomized, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study)","volume":"76","author":"Bardin","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.mehy.2020.109791_b0715","doi-asserted-by":"crossref","unstructured":"Ohta Y, Ishizuka A, Arima H, Hayashi S, Iwashima Y, Kishida M, Yoshihara F, Nakamura S, Kawano Y, Effective uric acid-lowering treatment for hypertensive patients with hyperuricemia, Hypertension Research 2016, 1\u20135.","DOI":"10.1038\/hr.2016.139"},{"issue":"2","key":"10.1016\/j.mehy.2020.109791_b0720","doi-asserted-by":"crossref","first-page":"102","DOI":"10.15171\/jcvtr.2017.17","article-title":"Safety and effect of high dose allopurinol in patients with severe left ventricular systolic dysfunction","volume":"9","author":"Ansari-Ramandi","year":"2017","journal-title":"J Cardiovasc Thorac Res"},{"issue":"6","key":"10.1016\/j.mehy.2020.109791_b0725","first-page":"1209","article-title":"Febuxostat in the management of hyperuricemia and chronic gout: a review","volume":"4","author":"Miao","year":"2008","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.mehy.2020.109791_b0730","doi-asserted-by":"crossref","unstructured":"Sica DA, Schoolwerth AC, Part 1. Uric acid and losartan, Current Opinion in Nephrology and Hypertension. 11(5):475\u201382.","DOI":"10.1097\/00041552-200209000-00001"},{"issue":"5","key":"10.1016\/j.mehy.2020.109791_b0735","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1536\/ihj.49.587","article-title":"Prednisone adding to usual care treatment for refractory decompensated congestive heart failure","volume":"49","author":"Zhang","year":"2008","journal-title":"Int Heart J"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720301900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720301900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:24:00Z","timestamp":1759692240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987720301900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":147,"alternative-id":["S0306987720301900"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2020.109791","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The differential role of uric acid \u2013 The purpose or cause of cardiovascular diseases?","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2020.109791","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109791"}}